Ortho Regenerative Technologies received a $500,000 grant from Axelys to develop its Ortho-M meniscus repair product.
The grant will accelerate development of the product's second clinical indication, according to a May 26 news release. Ortho Regenerative Technologies is behind orthobiologic products including Ortho-R.
Axelys is a nonprofit organization supporting public research and innovation.